{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T22:18:28Z","timestamp":1720995508535},"reference-count":42,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,3,28]]},"DOI":"10.1536\/ihj.19-205","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T22:06:06Z","timestamp":1584137166000},"page":"239-248","source":"Crossref","is-referenced-by-count":9,"title":["Factors Associated with a Large Decline in Renal Function or Progression to Renal Insufficiency in Hospitalized Atrial Fibrillation Patients with Early-Stage CKD"],"prefix":"10.1536","volume":"61","author":[{"given":"Lili","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"},{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinmei","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linghua","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinzhu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengyun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaosi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juxiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University"},{"name":"Jiangxi Key Laboratory of Molecular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Fuster V, Ryd\u00e9n LE, Cannom DS, <i>et al<\/i>. ACC\/AHA\/ESC. ACC\/AHA\/ESC 2006 Guidelines for the Management of Patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354.","DOI":"10.1161\/CIRCULATIONAHA.106.177292"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Alonso A, Lopez FL, Matsushita K, <i>et al<\/i>. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011; 123: 2946-53.","DOI":"10.1161\/CIRCULATIONAHA.111.020982"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Soliman EZ, Prineas RJ, Go AS, <i>et al<\/i>. Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J 2010; 159: 1102-7.","DOI":"10.1016\/j.ahj.2010.03.027"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Guo Y, Wang H, Zhao X, <i>et al<\/i>. Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation. Int J Cardiol 2013; 168: 4678-84.","DOI":"10.1016\/j.ijcard.2013.07.179"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yao X, Tangri N, Gersh BJ, <i>et al<\/i>. Renal outcomes in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol 2017; 70: 2621-32.","DOI":"10.1016\/j.jacc.2017.09.1087"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fanola CL, Mooney D, Cowan AJ, <i>et al<\/i>. Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants. Am Heart J 2017; 184: 150-5.","DOI":"10.1016\/j.ahj.2016.08.017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hijazi Z, Hohnloser SH, Andersson U, <i>et al<\/i>. Efficacy and safety of Apixaban compared with warfarin in patients with atrial fibrillation in relation to renal function over time: insights from the Aristotle randomized clinical trial. JAMA Cardiol 2016; 1: 451-60.","DOI":"10.1001\/jamacardio.2016.1170"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Chen SC, Lee WH, Hsu PC, <i>et al<\/i>. Association of the ratio of early mitral inflow velocity to the global diastolic strain rate with a rapid renal function decline in atrial fibrillation. PLOS ONE 2016; 11: e0147446.","DOI":"10.1371\/journal.pone.0147446"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Violi F, Pastori D, Perticone F, <i>et al<\/i>. Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study. BMJ Open 2015; 5: e008026.","DOI":"10.1136\/bmjopen-2015-008026"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Beyer-Westendorf J, Kreutz R, Posch F, Ay C. The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease. Int J Cardiol 2018; 253: 71-7.","DOI":"10.1016\/j.ijcard.2017.10.110"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chen SC, Chang JM, Tsai YC, <i>et al<\/i>. Ratio of transmitral E-wave velocity to early diastole mitral annulus velocity with cardiovascular and renal outcomes in chronic kidney disease. Nephron Clin Pract 2013; 123: 52-60.","DOI":"10.1159\/000351513"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chen SC, Su HM, Hung CC, <i>et al<\/i>. Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2750-8.","DOI":"10.2215\/CJN.04660511"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lang RM, Bierig M, Devereux RB, <i>et al<\/i>. Recommendations for chamber quantification: a report from the American Society of Echocardiography&apos;s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography 2005; 18: 1440-63.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137: 263-72.","DOI":"10.1378\/chest.09-1584"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Levey AS, Stevens LA, Schmid CH, <i>et al<\/i>. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"16","unstructured":"16. National Kidney F. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American journal of kidney diseases: the official journal of the National Kidney Foundation 2002; 39: S1-S266."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Levey AS, Inker LA, Matsushita K, <i>et al<\/i>. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 2014; 64: 821-35.","DOI":"10.1053\/j.ajkd.2014.07.030"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Olshansky B, Heller EN, Mitchell LB, <i>et al<\/i>. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 2005; 45: 2026-33.","DOI":"10.1016\/j.jacc.2005.03.020"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Chang WX, Asakawa S, Toyoki D, <i>et al<\/i>. Predictors and the subsequent risk of end-stage renal disease - usefulness of 30% decline in estimated GFR over 2 years. PLOS ONE 2015; 10: e0132927.","DOI":"10.1371\/journal.pone.0132927"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Chang WX, Arai S, Tamura Y, <i>et al<\/i>. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol 2016; 20: 58-70.","DOI":"10.1007\/s10157-015-1132-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Goette A, Kalman JM, Aguinaga L, <i>et al<\/i>. EHRA\/HRS\/APHRS\/SOLAECE expert consensus on Atrial cardiomyopathies: definition, characterisation, and clinical implication. J Arrhythm 2016; 32: 247-78.","DOI":"10.1016\/j.joa.2016.05.002"},{"key":"22","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/circ.104.17.2118","volume":"104","year":"2001","unstructured":"22. Fuster V, Ryd\u00e9n LE, Asinger RW, <i>et al<\/i>. ACC\/AHA\/ESC. ACC\/AHA\/ESC Guidelines for the management of patients with atrial fibrillation: executive summary A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and policy conferences (Committee to Develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 2001; 104: 2118-50.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rold\u00e1n V, Mar\u00edn F, Fern\u00e1ndez H, <i>et al<\/i>. Renal impairment in a &apos;real-life&apos; cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). Am J Cardiol 2013; 111: 1159-64.","DOI":"10.1016\/j.amjcard.2012.12.045"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Kizer JR, Bella JN, Palmieri V, <i>et al<\/i>. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J 2006; 151: 412-8.","DOI":"10.1016\/j.ahj.2005.04.031"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Abhayaratna WP, Seward JB, Appleton CP, <i>et al<\/i>. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006; 47: 2357-63.","DOI":"10.1016\/j.jacc.2006.02.048"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hamatani Y, Ogawa H, Takabayashi K, <i>et al<\/i>. Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep 2016; 6: 31042.","DOI":"10.1038\/srep31042"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Furukawa M, Io H, Tanimoto M, Hagiwara S, Horikoshi S, Tomino Y. Predictive factors associated with the period of time before initiation of hemodialysis in CKD stages 4 and 5. Nephron Clin Pract 2011; 117: c341-7.","DOI":"10.1159\/000321512"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kim SJ, Han SH, Park JT, <i>et al<\/i>. Left atrial volume is an independent predictor of mortality in CAPD patients. Nephrol Dial Transplant 2011; 26: 3732-9.","DOI":"10.1093\/ndt\/gfr118"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Bolignano D, Mattace-Raso F, Sijbrands EJ, Zoccali C. The aging kidney revisited: a systematic review. Ageing Res Rev 2014; 14: 65-80.","DOI":"10.1016\/j.arr.2014.02.003"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease. Clin Nephrol 2013; 80: 256-62.","DOI":"10.5414\/CN107905"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Halbesma N, Kuiken DS, Brantsma AH, <i>et al<\/i>. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 2006; 17: 2582-90.","DOI":"10.1681\/ASN.2005121352"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Turin TC, James M, Ravani P, <i>et al<\/i>. Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol 2013; 24: 1661-7.","DOI":"10.1681\/ASN.2012111118"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Olesen JB, Lip GY, Kamper AL, <i>et al<\/i>. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012; 367: 625-35.","DOI":"10.1056\/NEJMoa1105594"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Piccini JP, Stevens SR, Chang Y, <i>et al<\/i>. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R (2)CHADS(2) index in the ROCKET AF (Rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts. Circulation 2013; 127: 224-32.","DOI":"10.1161\/CIRCULATIONAHA.112.107128"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Chao TF, Tsao HM, Ambrose K, <i>et al<\/i>. Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation--the potential role beyond the CHA(2)DS(2)-VASc score. Heart Rhythm 2012; 9: 1755-60.","DOI":"10.1016\/j.hrthm.2012.06.039"},{"key":"36","unstructured":"36. Rold\u00e1n V, Mar\u00edn F, Manzano-Fernandez S, <i>et al<\/i>. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation? Thromb Haemost 2013; 109: 956-60."},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Banerjee A, Fauchier L, Vourc&apos;h P, <i>et al<\/i>. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol 2013; 61: 2079-87.","DOI":"10.1016\/j.jacc.2013.02.035"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Bansal N, Fan D, Hsu CY, Ordonez JD, Go AS. Incident atrial fibrillation and risk of death in adults with chronic kidney disease. J Am Heart Assoc 2014; 3: e001303.","DOI":"10.1161\/JAHA.114.001303"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Franczyk-Sk\u00f3ra B, Gluba A, Olszewski R, Banach M, Rysz J. Heart function disturbances in chronic kidney disease - echocardiographic indices. Arch Med Sci 2014; 10: 1109-16.","DOI":"10.5114\/aoms.2014.47822"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Navaravong L, Barakat M, Burgon N, <i>et al<\/i>. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2015; 26: 21-7.","DOI":"10.1111\/jce.12530"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Gerdts E, Wachtell K, Omvik P, <i>et al<\/i>. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension 2007; 49: 311-6.","DOI":"10.1161\/01.HYP.0000254322.96189.85"},{"key":"42","unstructured":"42. Henrard S, Vandenabeele C, Marien S, Boland B, Dalleur O. Underuse of anticoagulation in older patients with atrial fibrillation and CHADS2 score \u2265 2: are we doing better since the marketing of direct oral anticoagulants? Drugs Aging 2017; 34: 841-50."}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/2\/61_19-205\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T03:46:28Z","timestamp":1585367188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/2\/61_19-205\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,28]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-205","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,28]]}}}